© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Traveling Amid the COVID-19 Pandemic As A Cancer Survivor
The Definition of ‘Extraordinary’
Oncology Nurses Make ‘the Most Difficult Situation … Much Easier’
Immunotherapy Could “Provide A Whole New Realm” For Patients with Myeloma